Shweta Singh

Shweta Singh

Auto-generated profile, based on publicly available information

Shweta Singh

Amity University Haryana

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Drug Target Insights
Verified
Journal Article
Open access
PSPooja Sen
Pooja Sen
MVMukund Vijay
Mukund Vijay
SSShweta Singh
Shweta Singh
SHSAIF HAMEED
SAIF HAMEED
PVPooja Vijayaraghvan
Pooja Vijayaraghvan
Aspergilli are ubiquitous fungal pathogens associated with severe life-threatening infections, especially in immunocompromised patients. Azoles are the first line of defence in the fight against most Aspergillus -related infections. However, resistance to these therapeutic compounds has developed, which is mainly due to the existence of mutations in lanosterol 14 alpha-demethylase (Cyp51A), a crucial enzyme in the pathway that produces ergosterol and is the target of azole antifungals. Azole-based antifungal medications are ineffective because of infections brought on by azole-resistant Aspergillus species, leading to a high fatality rate. However, resistant Aspergillus isolates have also been isolated from azole-naïve patients. Global agricultural practices promote the use of azole fungicides to protect crops from phytopathogens. Usage of azole fungicides on a large scale has been linked to the development of resistance among Aspergillus species prevalent in the environment. The infections caused by these azoleresistant Aspergillus species cannot be treated by the available azole drugs, in turn leading to high morbidity and mortality rates. Thus, knowledge of the environmental drivers and comprehending the genetic basis of fungal drug resistance evolution is pertinent, considering increasing numbers of patients with COVID-19 infections who are sensitive to opportunistic fungal infections. This article emphasises the prevalence and underlying mechanisms of azole resistance in Aspergillus species, with a focus on environmental triggers and resistance development. It also highlights the need for regular surveillance of pesticide use in agriculture, detection of triazole-resistant Aspergillus species in environmental and clinical settings and development of new antifungal drugs.

1 January 2022 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ASAwad Yousef Shala
Awad Yousef Shala
SSShweta Singh
Shweta Singh
SHSAIF HAMEED
SAIF HAMEED
SKS.M. Paul Khurana
S.M. Paul Khurana
: Candida albicans is one of the main agents responsible for opportunistic pathogenic infections. The progressive emergence of fungal resistance to conventional antibiotics and its side effects, as well as treatment costs, are considered major limitations for antifungal drugs. It has drawn scientists' attention to the search for potential substitution and reliable therapeutic alternatives for the antifungal compounds from sources like medicinal plants, which contain numerous bioactive compounds such as essential oils. Essential oils (EO), apart from having lower toxicity and better biodegradability, are eco-friendly in nature as compared with conventional antibiotics. Furthermore, extracted essential oils have been reported to possess potent antimicrobial, antiinflammatory, and antioxidant properties that nominate them as promising natural candidates to combat numerous fungal ailments. Thus, the determination of antifungal efficacy of essential oil-bearing plants on Candida spp. will provide miscellaneous knowledge for future clinical studies that are required for the development of new formulations as alternative therapeutic agents to control the growth of Candida species. Therefore, this review summarizes the gist of major essential oils that have been investigated for their anti- Candida potential with some recommendations for further study.

1 September 2020 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
SSShweta Singh
Shweta Singh
ZFZEESHAN FATIMA
ZEESHAN FATIMA
SHSAIF HAMEED
SAIF HAMEED
Fungal pathogens pose a serious threat to public health. Widespread and prolonged usage of antifungal drugs has led to multidrug resistance (MDR) development in human fungal pathogen, Candida albicans. Among several mechanisms governing drug resistance in C. albicans, overexpression of drug efflux transporters by far remains the leading cause of MDR facilitated by overexpression of ATP Binding Cassette (ABC) or major facilitator superfamily (MFS) transporters. Hence targeting efflux pumps still represents a promising approach. In this study we analyzed the effect of octyl gallate (OG), a natural food additive, on drug efflux pump activity of C. albicans. Drug efflux pump activity was estimated by rhodamine 6G efflux (R6G) and nile red accumulation assay with Candida drug resistance protein 1 (CaCdr1p) over expressing strain. Gene and protein expression along with localization was studied by RT-PCR, Western blot and confocal microscopy. Ergosterol content was measured by alcoholic KOH method. OG specifically inhibits CaCdr1p activity belonging to ABC superfamily. Underlying mechanism confirmed competitive mode of inhibition by OG as revealed by Lineweaver-Burk plot. Furthermore, OG leads to reduced expressions ofCDR1, CaCdr1p and causes mislocalization respectively. Additionally, OG sensitizes azole sensitive and resistant clinical matched pair of isolates Gu4/Gu5 and led to impeded R6G efflux and depleted ergosterol content. OG being a potent inhibitor of CaCdr1p that chemosensitizes drug resistant C. albicans warrants further studies to be exploited as an effective antifungal agent.